Loading...
XNAS
CERO
Market cap665kUSD
Dec 05, Last price  
0.11USD
1D
-5.58%
1Q
-98.20%
IPO
-98.93%
Name

Phoenix Biotech Acquisition Corp

Chart & Performance

D1W1MN
XNAS:CERO chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
-100.00%
0254,8310
Net income
-11m
L+1,560.73%
-315,547-667,736-11,089,262
CFO
-6m
L+430.10%
-697,109-1,092,247-5,789,987

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.
IPO date
Oct 06, 2021
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFY
2024‑122022‑122021‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT